Bod Science Limited (BOD.AX)

0.0240 0.0000 (0.00%) At close: 02:59PM AEST

Bod Science Limited

376 New South Head Road
Level 2
Double Bay, NSW 2028
Australia
61 2 9199 5018
https://bodscience.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Joanne Patterson	CEO, Executive Director & Member of Medical Advisory Board	477.02k	N/A	N/A
Mr. Adrian Sturrock	Chief Financial Officer	377.63k	N/A	N/A
Mr. Craig Weller	CTO & Member of Medical Advisory Board	384.34k	N/A	N/A
Dr. Adele Hosseini	Chief Scientific Officer & Member of Medical Advisory Board	N/A	N/A	N/A
Mr. Alan Dworkin ACIS, BBus, CA	Advisor	N/A	N/A	N/A
Ms. Carlie Hodges	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets. The company provides Flexofytol, an anti-inflammatory derived from a scientifically validated and clinically trialed turmeric extract that helps in improving joint pain and stiffness, joint health, limiting the ageing of cartilage, and reducing inflammation caused by mild arthritis; and Sedistress, a passion flower extract that reduces the symptoms of stress, anxiety, and insomnia, as well as contract manufacturing services. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Double Bay, Australia.

Corporate governance

Bod Science Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.